Pharmacotherapy of Diabetes Focused on Stroke
- Author:
Young Sang LYU
1
;
Jin Hwa KIM
;
Sang Yong KIM
Author Information
- Publication Type:Review
- Keywords: Diabetes mellitus; Stroke; Diabetes complications; Hypoglycemic agents
- MeSH: Cardiovascular Diseases; Cause of Death; Diabetes Complications; Diabetes Mellitus; Drug Therapy; Hypoglycemic Agents; Stroke; Vascular Diseases
- From:Journal of the Korean Neurological Association 2019;37(3):235-250
- CountryRepublic of Korea
- Language:Korean
- Abstract: Cardiovascular disease, including stroke, is one of the major causes of death in diabetes. Numerous studies have long suggested reducing macrovascular complication such as ischemic vascular disease through intensive glycemic control, but none was successful proving the effect of glycemic control. Recently, new possibilities in cardiovascular disease reduction have been proposed through cardiovascular safety trials of newly developed anti-hyperglycemic agents. The purpose of this review is to introduce the traditional and newly developed anti-diabetic medications and review their effects regarding cardiovascular outcomes mainly focusing on stroke.
